Stay updated on Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page's Revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page metadata.
    Difference
    0.1%
    Check dated 2026-08-30T22:31:04.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, representing an internal site update with no changes to the study information visible to users.
    Difference
    0.1%
    Check dated 2026-08-09T08:53:59.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.6.3 to v3.6.4. This indicates a small update to the page’s content or interface without altering the study data.
    Difference
    0.1%
    Check dated 2026-07-25T17:02:43.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating an internal update to the page template used for the study details. It does not alter the displayed study information or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-07-04T05:25:36.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page's revision badge changed from v3.6.0 to v3.6.2, signaling a backend/template update rather than changes to the study details. No study content appears to be affected.
    Difference
    0.1%
    Check dated 2026-06-27T03:21:01.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The page adds recruitment status clarity and new user-guidance sections to help readers understand the study record and how to participate.
    Difference
    0.5%
    Check dated 2026-06-12T16:28:21.000Z thumbnail image

Stay in the know with updates to Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Umbralisib Plus Pembrolizumab in Hodgkin Lymphoma Clinical Trial page.